Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
How Much Don't You Know About Your Financial Adviser?
Athersys reports on progress in Phase 2 study of MultiStem for ischemic stroke
Athersys Reports on Progress in Phase 2 Study of MultiStem for Ischemic Stroke
Can Stem Cells Regenerate Your Portfolio? Stephen Dunn Says Yes
Athersys CEO to Present on September 24, 2012 at the Noble Financial Life Sciences Exposition
IBC Life Sciences to hsot a conference
The Next Big Growth Sector In Health Care: Stem Cell Therapy
Drug buoys Cleveland company's stem-cell aspiration
Osiris Stem Cell Drug Approval Bodes Well For Athersys
Athersys Management Discusses Q2 2012 Results - Earnings Call Transcript
Athersys reports Q2 EPS (13c), consensus (14c)